AU7333794A - Single-chain immunotoxin compositions and methods for preventing secondary cataracts - Google Patents

Single-chain immunotoxin compositions and methods for preventing secondary cataracts

Info

Publication number
AU7333794A
AU7333794A AU73337/94A AU7333794A AU7333794A AU 7333794 A AU7333794 A AU 7333794A AU 73337/94 A AU73337/94 A AU 73337/94A AU 7333794 A AU7333794 A AU 7333794A AU 7333794 A AU7333794 A AU 7333794A
Authority
AU
Australia
Prior art keywords
methods
preventing secondary
secondary cataracts
chain immunotoxin
immunotoxin compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73337/94A
Inventor
Robert M Gould
Peter J. Kelleher
Thomas L Wallace
Mark Stephan Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Houston Biotechnology Inc
Original Assignee
Houston Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houston Biotechnology Inc filed Critical Houston Biotechnology Inc
Publication of AU7333794A publication Critical patent/AU7333794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU73337/94A 1993-08-02 1994-07-15 Single-chain immunotoxin compositions and methods for preventing secondary cataracts Abandoned AU7333794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US101329 1987-09-25
US10132993A 1993-08-02 1993-08-02
PCT/US1994/007919 WO1995003828A1 (en) 1993-08-02 1994-07-15 Single-chain immunotoxin compositions and methods for preventing secondary cataracts

Publications (1)

Publication Number Publication Date
AU7333794A true AU7333794A (en) 1995-02-28

Family

ID=22284079

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73337/94A Abandoned AU7333794A (en) 1993-08-02 1994-07-15 Single-chain immunotoxin compositions and methods for preventing secondary cataracts

Country Status (2)

Country Link
AU (1) AU7333794A (en)
WO (1) WO1995003828A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033492A1 (en) * 1994-06-09 1995-12-14 Houston Biotechnology Incorporated Methods and compositions for modulation of wound healing
CA2187482A1 (en) * 1995-10-13 1997-04-14 Eri Inoue Pharmaceutical composition
CA2421070A1 (en) 2000-09-01 2002-03-14 International Bioimmune Systems, Inc. The identification and development of specific monoclonal antibodies to squamous cell carcinoma
EP1411962B1 (en) 2001-03-15 2011-01-19 Neogenix Oncology, Inc. Monoclonal antibody therapy for pancreas cancer
JP2022525318A (en) * 2019-03-15 2022-05-12 ラトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー CD147 Chimeric Antigen Receptor and Method of Use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055291A (en) * 1986-11-04 1991-10-08 Baylor College Of Medicine Compositions for preventing secondary cataracts

Also Published As

Publication number Publication date
WO1995003828A1 (en) 1995-02-09

Similar Documents

Publication Publication Date Title
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU8119794A (en) Method and means for prevention of cataract
AU5983994A (en) Universal implant abutment
AU3609795A (en) Ophthalmic and aural compositions containing diclofenac potassium
AU6484894A (en) Combination stopper-shield closure
AU5295593A (en) Polymerization processes and toner compositions therefrom
AU7289596A (en) Tricyclic fused compounds and pharmaceutical compositions containing them
AU5494294A (en) Hop extract and use thereof
AU2782595A (en) Non-silicated soft metal safe product
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU7076194A (en) Polyphenol derivative compositions and preparation thereof
AU6959694A (en) Antineoplastic compositions and methods of use
AU6795694A (en) Endoprosthesis cutting-off device
AU5936594A (en) Sunscreen compositions
AU5270393A (en) Packing list manifest
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU1290597A (en) Synergistic bactericide
AU6589494A (en) Method and compositions for disrupting the epithelial barrier function
AU6995594A (en) Aryltriflates and related compounds
AU7437094A (en) Disinfectant-detergent composition
AU4471897A (en) Secondary cataract inhibitor
AU5773994A (en) Cable-making compositions
AU7333794A (en) Single-chain immunotoxin compositions and methods for preventing secondary cataracts
IL109036A0 (en) Method and compositions for disrupting the epithelial barrier function